Voluntis announces changes to its board of directors and management structure. As Voluntis continues to simplify its organization in line with its strategic roadmap, the Board of Directors has approved a reduction in its size. In conjunction with this evolution, Roberta Herman and Nicolas Cartier have resigned as members of the Board of Directors due to each of them taking on new leadership roles: Dr. Herman as President and CEO of Joslin Diabetes Center and Mr. Cartier as COO of Merieux NutriSciences. This revised Board structure, with six directors of which two are independent, became effective July 30, 2020. In parallel, the Company organization has been simplified to sustain competitiveness and promote innovation and talents, whilst assuring continuity in the Company’s skills, culture and values. The Executive Committee and the Global Management Committee are now merged into a single Management Committee, led by the Chief Executive Officer, Pierre Leurent. All commercial activities are now regrouped under a single unit, headed by Romain Marmot, appointed Chief Business Officer. As a result of the organizational changes, the Chief Operations Officer role has been removed and Alexandre Capet, former COO in Europe, is leaving the company to pursue other interests.